Detalhe da pesquisa
1.
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Circulation
; 143(12): 1215-1223, 2021 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33461308
2.
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
N Engl J Med
; 380(16): 1509-1524, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30883055
3.
ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor.
Am Heart J
; 249: 76-85, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35472303
4.
Systematic Screening for Atrial Fibrillation in Patients at Moderate-to-High Risk of Strokeã- Potential to Increase the Atrial Fibrillation Detection Rate (SCAN-AF).
Circ J
; 86(8): 1245-1251, 2022 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35125371
5.
Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.
Circulation
; 141(20): 1618-1627, 2020 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32223444
6.
Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition.
Arterioscler Thromb Vasc Biol
; 40(11): 2678-2685, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32907366
7.
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Circulation
; 140(23): 1921-1932, 2019 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31557056
8.
Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.
Circulation
; 141(9): 781-783, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707833
9.
Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.
Circulation
; 140(23): 1960-1963, 2019 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553201
10.
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial.
Open Heart
; 9(1)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172988
11.
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
J Am Coll Cardiol
; 79(5): 417-427, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35115097
12.
Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial.
JAMA Cardiol
; 7(7): 682-689, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612866
13.
Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial.
J Am Heart Assoc
; 10(24): e023143, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34873913